Quantcast
Skip to Main Content

News & Research

Donate Today!
blue speech bubbles

Connect with Others

Discuss healthy eating habits in our "Eating Right" Message Boards.

Treating Diabetes and Coronary Artery Disease

Findings of the international Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial did not demonstrate a significant advantage of revascularization over medical therapy for diabetes patients with coronary artery disease (CAD).

The 2,368 participants in the study all had both type 2 diabetes and CAD, and they were randomized to receive either revascularization or medical therapy alone for CAD, and either insulin provision or insulin sensitization.

In an average follow-up of 5.3 years, the treatment groups demonstrated similar mortality rates, with the five-year survival rate ranging from 87.8 percent in the medical-therapy group to 88.3 percent in the revascularization group. In addition, all treatment groups had a similar proportion of patients without a major cardiovascular event.

The authors note, "The findings reinforce those of the COURAGE trial, which supported medical therapy as a reasonable initial approach in these patients."

(c)Copyright 2009 Information, Inc.

Medscape (11/06/09) Krumholz, Harlan M. 


The information contained in this article does not necessarily reflect the views and opinions of the American Diabetes Association.

(c) Copyright 2010 Information, Inc.

Diabetes Research

Research Foundation

Discover the latest findings from ADA-funded research

What You Need to Know From A-Z

Guide to Nutritional Supplements 72x72

About 40 of most popular alternative therapies for diabetes

Stop Diabetes
try { var gwoTracker=_gat._getTracker("UA-2200333-49"); gwoTracker._setDomainName(".diabetes.org"); gwoTracker._trackPageview("/2221214280/test"); }catch(err){}

70th Scientific Sessions

SciSessions

Join your colleagues at the world’s largest and most prestigious diabetes meeting.

Powered by Convio
nonprofit software